<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ectoenzyme nucleotide <z:chebi fb="2" ids="18361">pyrophosphate</z:chebi> phosphodiesterase 1 (ENPP1) is an inhibitor of insulin-induced activation of the insulin receptor </plain></SENT>
<SENT sid="1" pm="."><plain>There is strong evidence from several previous studies that a common coding variant of ENPP1 (K121Q) and a three-marker haplotype (Q121, IVS20delT-11, and G+1044TGA) are associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We examined the impact of ENPP1 variation on type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001513'>obesity</z:hpo> in a large U.K. genetic association study </plain></SENT>
<SENT sid="3" pm="."><plain>We genotyped the three previously associated polymorphisms in 2,363 type 2 diabetic case and 4,045 control subjects, as well as 1,681 subjects from 529 type 2 diabetic families </plain></SENT>
<SENT sid="4" pm="."><plain>We used the same subjects for morbid and moderate <z:hpo ids='HP_0001513'>obesity</z:hpo> association studies </plain></SENT>
<SENT sid="5" pm="."><plain>For type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, moderate and morbid <z:hpo ids='HP_0001513'>obesity</z:hpo>, and for both the Q121 and three-marker haplotype, our results exclude with &gt;95% confidence the effect sizes from previous studies (Q121 allele: odds ratio 1.02 [95% CI 0.93-1.12], P = 0.61; 1.00 [0.85-1.18], P = 0.99; and 0.92 [0.70-1.20], P = 0.41; three-marker haplotype: 1.10 [0.96-1.26], P = 0.17; 0.97 [0.77-1.23], P = 0.81; and 0.86 [0.57-1.30], P = 0.46 for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, moderate, and morbid <z:hpo ids='HP_0001513'>obesity</z:hpo>, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>A K121Q type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> meta-analysis of <z:hpo ids='HP_0000001'>all</z:hpo> previously published studies remained significant after the inclusion of this study (1.25 [1.10-1.43], P = 0.0007), although there was some evidence of publication bias </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, we find no evidence that previously associated variants of ENPP1 are associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:hpo ids='HP_0001513'>obesity</z:hpo> in the U.K. population </plain></SENT>
</text></document>